glp 1 ibd GLP-1 obesity "inflammatory bowel disease" Frontiers | GLP-1 and GLP-2

A landmark 2025 meta-analysis published in the Journal of the American College of Cardiology pooled 21 randomized controlled trials covering 99,599 patients and found high-certainty evidence that GLP-1 receptor agonists produced: 12% reduction in all-cause death (IRR 0.88

At Cape Fear Physical Medicine and Rehab, we are committed to providing comprehensive, evidence-based care to help our patients achieve optimal health and functional outcomes

In vitro research shows that curcumin, a constituent of turmeric, displaces the binding of estrogen to its receptors

Starting orforglipron at a full maintenance dose immediately after discontinuing the injectable could produce excessive GLP-1 receptor stimulation and amplified GI side effects

2016;7(2):e0221002215

Clinical studies have proven that there has been a significant decrease in body weight for participants using semaglutide GLP-1 compared to those on a placebo